Oncology News | pharmaphorum

News

FDA says yes to MedCognetics breast cancer screening AI

Digital health company MedCognetics has picked up an FDA approval for QmTRIAGE, its artificial intelligence-powered software for detecting breast cancer in medical images.

News

Merck and Moderna's mRNA cancer vaccine aces its first effic...

The mRNA technology that was deployed so effectively in vaccines against COVID-19 has now been found to offer similar promise against cancer, according to Merck & Co and Moderna.

News

ASH roundup: late breakers take the stage

The final day of the ASH congress always includes a session on late-breaking studies, and this year was no exception, with presentations on Novartis' iptacopan in paroxysmal nocturnal haemo

News

Mirati challenges Amgen with FDA okay for KRAS drug

Amgen has its first direct competition in the KRAS inhibitor class following FDA approval of Mirati's adagrasib as Krazati for a form of lung cancer.

News

Nordic Nanovector board resigns en masse as merger bid fails

Nordic Nanovector's plan to emerge from its current troubles by merging with APIM Therapeutics has hit an insurmountable hurdle – in the shape of its own shareholders.

News

ASH: J&J makes case for just-filed GPRC5D drug talquetamab

Johnson & Johnson is in pole position to bring a drug targeting GPRC5D to market as a new therapeutic approach to multiple myeloma, and told delegates at ASH yesterday why its talquetam

FDA says yes to MedCognetics breast cancer screening AI

Merck and Moderna's mRNA cancer vaccine aces its first effic...

ASH roundup: late breakers take the stage

Mirati challenges Amgen with FDA okay for KRAS drug

Nordic Nanovector board resigns en masse as merger bid fails

ASH: J&J makes case for just-filed GPRC5D drug talquetamab

CMS aims for broader GLP-1 access via federal programmes

How to meet your physicians where they are online

News

Editor's Picks